TECHPOINT ELECTRONIC SOLUTIONS LIMITED
Company number 06064546 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Here is a comprehensive financial health assessment for TechPoint Electronic Solutions Limited, applying a diagnostic approach to evaluate the company's vital signs, symptoms, and overall condition.
1. Financial Health Score: B+
Explanation: The company receives a strong B+ grade. The core operational "engine" of the business is highly robust, demonstrating excellent profitability and revenue generation. However, the grade is tempered by a significant drop in cash reserves and a sharp increase in total liabilities, which are classic symptoms of a major growth spurt and corporate restructuring. The patient is fundamentally healthy but currently enduring the physical stress of a significant transformation.
2. Key Vital Signs
- Heart Rate (Revenue): £11.04 million (Year ending July 2025). While down from the £14.58 million reported in the 12-month period ending March 2024, this is a healthy pulse for a medium-sized enterprise, especially considering the strategic integration of the Supply Chain Solutions (SCS) operation during the year.
- Blood Pressure (Profitability): £3.16 million in operating profit (excluding one-off costs). This indicates a very strong margin of approximately 28%. The business is highly efficient at converting sales into profit.
- Muscle Mass (Net Assets): £6.29 million. Shareholders' funds have doubled from £3.01 million in the prior period. The company is building significant long-term strength and equity.
- Hydration Levels (Cash Reserves): £332,613. This is a notable drop from £2.21 million in July 2024 and £1.39 million in March 2024. The company is currently operating with low liquidity, a direct result of heavy investment in its new "super site" facility and the SCS integration.
- Cholesterol (Total Liabilities): £15.63 million. Liabilities have surged from £2.19 million. While this looks alarming on the surface, it is largely attributable to financing the new Basingstoke headquarters and group-level treasury facilities.
3. Diagnosis
Symptoms Analysis: The financial data reveals a company in the midst of a "puberty" or major growth spurt. The symptoms—spiking liabilities and draining cash—are not signs of a failing business, but rather the financial equivalent of growing pains. The company has incurred approximately £250,000 in transition costs and £240,000 in duplicated rent to facilitate its move to a flagship Basingstoke facility and the integration of the SCS operation.
Overall Condition: The underlying business health is excellent. The ability to generate £3.16 million in operating profit while simultaneously absorbing the disruption of a major facility move and corporate integration speaks to a highly resilient operational model. The low cash levels and high liabilities represent acute, short-term stress rather than chronic disease, especially given the explicit support from the Group's shared financing facilities and treasury support. The directors have wisely opted not to pay a dividend, retaining nutrients within the body to fuel the ongoing transition.
4. Recommendations
To restore full financial wellness and balance, the following actions are recommended: - Intravenous Fluids (Liquidity Management): With cash reserves depleted to £332k, close monitoring of daily cash flow is critical. The company should ensure that group treasury facilities remain accessible and that working capital does not become strained during the final stages of the facility transition. - Cholesterol Reduction (Debt Servicing): The dramatic increase in liabilities must be carefully managed. Once the transition is complete, the company should use its strong profit generation to actively pay down short-term and medium-term debts to restore a healthier asset-to-liability ratio. - Monitoring Vital Signs (KPI Tracking): Management should maintain strict oversight of the integration process. The £3.16 million operating profit proves the core business is strong; the focus must now be on ensuring the SCS integration and the new "super site" deliver the anticipated synergies without allowing operational costs to bloat. - Rest and Recovery (Cost Normalization): The company should work to quickly eliminate the one-off costs associated with the move. Once the duplicated rent and project management fees are stripped out, the true, enhanced profitability of the enlarged entity should become visible.